Corporate / M&A

IP / IT

Employment and Executive Compensation

Homburger News

Homburger advises Eli Lilly on the acquisition of LimmaTech Biologics

On May 26, 2026, Eli Lilly and Company (NYSE: LLY) announced the acquisition of LimmaTech Biologics AG for up to USD 780 m in cash, inclusive of an upfront payment and additional potential payments based upon the achievement of certain clinical and regulatory milestones. LimmaTech Biologics is developing vaccines against bacterial pathogens for which rising antimicrobial resistance is steadily closing therapeutic options.
The Homburger team advising Eli Lilly includes Anna Peter, Bianca Nedwed, Daniel Kuhn, Jana Waldvogel and Ivo Graf (all Corporate / M&amp;A), Joel Fink (IP / IT), Jeremy Reichlin and Giulia Menegon (both Employment and Executive Compensation) as well as Stefan Oesterhelt and Juliette Buob (both Tax).

Capital Markets

Financial Market Regulation

Homburger advises EQT on the sale of ca. 8.4% of Galderma’s share capital via an accelerated bookbuilding process 

On October 27, 2025, a consortium led by EQT, consisting of Sunshine SwissCo GmbH, the Abu Dhabi Investment Authority (ADIA) and Auba Investment Pte. Ltd. (all acting as the Sellers), announced the launch of an accelerated bookbuilding process to professional investors in Switzerland and to qualified investors outside Switzerland, which led to the successful placement of 20 m shares in Galderma Group AG at a price of CHF 130 per share (the Placement), raising ca. CHF 2.6 bn in total.
The Sellers will remain shareholders of ca. 24.6% of the share capital of Galderma. EQT’s representation on the board of directors of Galderma remains unchanged as a result of the Placement. In connection therewith, the Sellers have agreed to a 90-day lock-up period, subject to certain customary exceptions, with respect to their remaining holding in Galderma.
The Placement is expected to be settled on October 30, 2025. Citigroup Global Markets Limited, Goldman Sachs International, Jefferies GmbH, Merrill Lynch International, Morgan Stanley &amp; Co. International plc and UBS AG are acting as Joint Global Coordinators and Joint Bookrunners in the Placement.
Homburger acted as transaction counsel to EQT.
The Homburger team was led by Frank Gerhard and Margrit Marti (Corporate / M&amp;A, Capital Markets) and included Estelle Piccard, Lucas Forrer, Jannis Zafeirakos and Jana Waldvogel (all Corporate / M&amp;A, Capital Markets), Micha Fankhauser (Financial Market Regulation) as well as Stefan Oesterhelt (Tax).

Competition

Regulatory

Share-Image Teamplate Deals-and-Cases

On January 11, 2024, ABB announced that it has acquired the Swiss-based startup Sevensense Robotics AG (Sevensense Robotics). Founded in 2018 as a spin-off from the Swiss Federal Institute of Technology (ETH), Sevensense Robotics is a leading provider of AI-enabled 3D vision navigation technology for autonomous mobile robots (AMRs). The navigation technology developed by Sevensense Robotics enables AMRs to take intelligent decisions, differentiating between fixed and mobile objects in dynamic environments. ABB plans to continue offering this technology under the product name Sevensense across segments including material handling, cleaning and other service robotics fields. Sevensense has the potential to impact robotics far beyond AMRs, leading to greater efficiency, flexibility and accuracy throughout production and intralogistics.
The Homburger team was led by Lorenzo Togni and included Simone Schmid, Isabelle Cordey and Jana Waldvogel (all Corporate / M&amp;A) as well as Richard Stäuber and Nicolas Stocker (both Competition / Regulatory), Luca Dal Molin and Hélène Bruderer (both IP / IT) and Jonas Stähli (Tax).

Jana
Waldvogel

Homburger advises Eli Lilly on the acquisition of LimmaTech Biologics

Homburger advises EQT on the sale of ca. 8.4% of Galderma’s share capital via an accelerated bookbuilding process

Homburger advised ABB on its acquisition of Sevensense Robotics AG

Join the Team

Jana Waldvogel

Career

Languages

Bar Registration

Teams

JanaWaldvogel

Homburger advises Eli Lilly on the acquisition of LimmaTech Biologics

Homburger advises EQT on the sale of ca. 8.4% of Galderma’s share capital via an accelerated bookbuilding process

Homburger advised ABB on its acquisition of Sevensense Robotics AG

Join the Team

Jana Waldvogel

Career

Languages

Bar Registration

Teams

Jana
Waldvogel